| ORDAVVEQ PFIZER INC.
2107186 14 May 2021 | on 26 Jul 2023 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders; pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brain diseases and disorders, namely muscular dystrophy; Pharmaceutical preparations for the treatment of bone growth disorders; Pharmaceutical preparations for the treatment of the central nervous system, namely brain diseases and central nervous system movement disorders; Pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal, blood, and diseases and disorders; Pharmaceutical preparations for the treatment of auto-immune diseases and disorders, namely rheumatoid arthritis, systemic lupus, alopecia areata, and systemic sclerosis; Pharmaceutical preparations for the treatment of hypertension, menopause symptoms, obesity, stroke, arthritis, and pain; Pharmaceutical preparations for the treatment of cancer; Anti-infectives, anti-inflammatories, anti-viral agents, human vaccines; Pharmaceutical preparations for use in discouraging smoking habits; Pharmaceutical preparations for the treatment of kidney and liver disease and disorders; Pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely cachexia, diabetes, hypoglycemia, muscular dystrophy, obesity, sickle cell disease, non-alcoholic steatohepatitis (NASH) and anemia; Pharmaceutical preparations for the treatment of skin and dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, and viral skin infections. Pharmaceutical preparations for the treatment of muscular dystrophy. | | | ORDAYBA BioCryst Pharmaceuticals, Inc.
1926952 24 Oct 2018 | on 27 Oct 2021 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of hereditary angioedema | | | ORDAX BASF CORPORATION
(A DELAWARE CORPORATION)
1051828 22 Mar 2000 | on 09 Apr 2003 | Class 005 Class 005 Pharmaceutical Products Insecticides, larvicides, fungicides, herbicides, pesticides, molluscicides, nematocides, rodenticides and preparations for killing weeds and destroying vermin. | | | ORDA-FLO WILSON JONES COMPANY
291267 13 Aug 1965 | on 15 Aug 1997 | Class 007 Class 007 Machinery Products Automated office paper-word delivery device. | |